Clinical Trials Browser

Phase 1 × Recruiting × Lymphoma, Extranodal NK-T-Cell × Clear all

NCT07382817 2026-02-27

Phase 1 Study of JV-394 Autologous Anti-CD94 CAR T for r/r CD94+ T/NK Cell Neoplasms

Phase 1 Recruiting

Neoplasms, Lymphoma, T-Cell, Lymphoma, Extranodal NK-T-Cell

NCT04288726 2025-07-20

Allogeneic CD30.CAR-EBVSTs in Patients With Relapsed or Refractory CD30-Positive Lymphomas

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, Extranodal NK-T-Cell

NCT06732492 2024-12-13

RD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies

Phase 1 Recruiting

Lymphoma, Extranodal NK-T-Cell